Market Value:
The global Swine Mycoplasma Pneumonia Live Vaccine market was valued at US$ 220.2 million in 2023 and is projected to reach US$ 329.6 million by 2030, at a CAGR of 5.9% during the forecast period.
(2024-2030)
By Types:
168 Strains
RM48 Strains
By Applications:
Piglets
Adult Pigs
